Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-06

Clinical Trial Update: Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC [Phase 4]

View source ↗

Summary

Phase 4 trial comparing cefotaxime, ceftriaxone, and ciprofloxacin for spontaneous bacterial peritonitis in patients with liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefotaxime (Cefotaxime)
  • Ciprofloxacin (Ciprofloxacin hydrochloride)
  • ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Korea University | Conditions: SBP, Liver Cirrhosis | Phase 4 | Status: COMPLETED